Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06951490Enrolling By Invitation

PillSense Use in Anemia and Hemoccult

Role: collaborator

NCT06500468Not ApplicableRecruiting

PillSense for Suspected Upper Gastrointestinal Bleeding

Role: collaborator

NCT05385224Not ApplicableCompleted

PillSense System for Detecting UGI Bleed

Role: lead

NCT05631639Not ApplicableCompleted

Detection of Upper Gastrointestinal (GI) Bleeding Using a Novel Bleeding Sensor Capsule -A Pilot Study

Role: lead

NCT05631652Not ApplicableCompleted

Detection of Upper Gastrointestinal (GI) Bleeding Using a Novel Bleeding Sensor Capsule -Healthy Volunteers Study

Role: lead

All 5 trials loaded